Search Content

This is an outpatient, 2-arm, Phase 3, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of REL-1017 once daily (QD) as an adjunctive treatment of Major Depressive Disorder.

Have you been struggling with anxiety symptoms?

The purpose of this research study is to determine whether cannabidiol (CBD), a non-psychoactive part of cannabis, is an effective treatment for social anxiety disorder (SAD), and to better understand how CBD might improve SAD symptoms.

Talkspace is working on an NIH-funded, 

The UWM Anxiety Disorder Lab and the UWM Affective Neuroscience Lab are currently testing computer-based treatment programs designed to help adults (aged 18-60) suffering from problematic repetitive behaviors.

First-line pharmacological treatments for anxiety disorders include antidepressants. Unfortunately, treatment response rates to these standard agents are less than optimal, with 40–60% of patients continuing to have residual, impairing symptoms.

Baylor College of Medicine and the University of North Carolina would like to present the Latin American Trans-Ancestry Initiative for OCD Genomics, or LATINO. Led by Drs.

We are currently enrolling participants for a home-based clinical trial investigating two CBD Oil formulations in the treatment of PTSD.